BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32556197)

  • 1. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.
    Chen Y; Li Y; Gao H
    Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
    Gao H; Sun X; Wang H; Zheng Y
    Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
    Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer.
    Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG
    Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
    Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
    Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
    Wang R; Zhao L; Ji L; Bai L; Wen Q
    Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer.
    Gao Y; Wang F; Zhang L; Kang M; Zhu L; Xu L; Liang W; Zhang W
    Cancer Med; 2020 Feb; 9(4):1515-1528. PubMed ID: 31894666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
    Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
    BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
    He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
    Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
    Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
    Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.
    Yang S; Gong Z; Liu Z; Wei M; Xue L; Vlantis AC; Zhang Y; Chan JY; van Hasselt CA; Zeng X; Qiu S; Tang N; Du J; Wei W; Tong MC; Chen GG
    Front Endocrinol (Lausanne); 2021; 12():708248. PubMed ID: 34557159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.